Caption Management
MIRM icon

Caption Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Caption Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,000
Closed -$9.24M – 1902
2026
Q1 		$9.24M Buy
+100,000
New +$9.41M 0.05% 359
2025
Q4 		– Sell
-11,800
Closed -$865K – 1889
2025
Q3 		$865K Buy
+11,800
New +$750K 0.01% 1153
2024
Q4 		– Sell
-99,500
Closed -$3.88M – 1686
2024
Q3 		$3.88M Buy
99,500
+63,900
+179% +$2.55M 0.06% 367
2024
Q2 		$1.22M Buy
35,600
+17,600
+98% +$461K 0.02% 615
2024
Q1 		$452K Buy
+18,000
New +$495K 0.01% 888

Other funds holding MIRM

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return